IFRX
InflaRx NV
NASDAQ · Healthcare · Biotechnology · DE
$1.37
−15.74%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.56x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 2.79x
Liquidity & coverage
- Current ratio
- 7.26x
- Quick ratio
- 7.26x
- Cash ratio
- 6.87x
- Interest coverage
- -547.04x
- EBITDA / interest
- -484.18x
- Working capital
- $116.8M
Cash & dividend
- FCF / debt
- -23.35x
- Cash flow / debt
- -23.23x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026